The big question in pharma is: where does this disruption stand and where is it heading? That was the main topic of conversation during the Digital Health’s Disruption of Pharma panel discussion at the recent mHealth Summit.
Moderated by Brian Dolan, editor of MobiHealthNews, the panel included Joe Dustin, principal of mobile health at Medidata—a technology company that serves the clinical trials industry; Jane Rhodes, senior director of new initiatives, Innovation Hub at Biogen –a biotechnology company that develops products for multiple sclerosis (MS) and other neurological conditions; and Drew Schiller, co-founder and chief technology officer at Validic— the leading platform for connecting healthcare companies with digital health apps, wearables and in-home medical devices.
For more details, download White Paper here:
Digital Health in Pharma: Exploring the Potential Impact